AIMS: Cardiac resynchronization therapy is an accepted treatment for heart failure but it may be necessary to explant these systems along with their leads. The evidence base for coronary sinus (CS) lead extractions is limited. We aimed to evaluate the percutaneous removal of these leads and the utility of laser extraction when necessary. METHODS AND RESULTS: Of 265 patients referred for lead extraction between January 2004 and June 2008, 32 (12.1%) involved CS leads (30 males, mean age 67 years). Mean implantation time was 26.5 +/- 28.7 months (range 1-116 months). Indications for extraction were pocket infection (34.4%), lead malfunction (43.8%), skin erosion (15.6%), and endocarditis (6.2%). Twenty-eight (87.5%) CS leads were removed with manual traction, with laser utilized in four cases (12.5%). No major complications of CS laceration, pericardial effusion, emergency surgery, or death occurred. CONCLUSION: Our experience supports the percutaneous extraction of CS leads as a safe and effective procedure including the utility of laser when necessary.
AIMS: Cardiac resynchronization therapy is an accepted treatment for heart failure but it may be necessary to explant these systems along with their leads. The evidence base for coronary sinus (CS) lead extractions is limited. We aimed to evaluate the percutaneous removal of these leads and the utility of laser extraction when necessary. METHODS AND RESULTS: Of 265 patients referred for lead extraction between January 2004 and June 2008, 32 (12.1%) involved CS leads (30 males, mean age 67 years). Mean implantation time was 26.5 +/- 28.7 months (range 1-116 months). Indications for extraction were pocket infection (34.4%), lead malfunction (43.8%), skin erosion (15.6%), and endocarditis (6.2%). Twenty-eight (87.5%) CS leads were removed with manual traction, with laser utilized in four cases (12.5%). No major complications of CS laceration, pericardial effusion, emergency surgery, or death occurred. CONCLUSION: Our experience supports the percutaneous extraction of CS leads as a safe and effective procedure including the utility of laser when necessary.
Authors: Seth Sheldon; Paul A Friedman; David L Hayes; Michael J Osborn; Yong-Mei Cha; Robert F Rea; Samuel J Asirvatham Journal: J Interv Card Electrophysiol Date: 2012-05-15 Impact factor: 1.900
Authors: Andrzej W Kutarski; Wojciech Jacheć; Łukasz Tułecki; Konrad Tomków; Paweł Stefańczyk; Wojciech Borzęcki; Dorota Nowosielecka; Marek Czajkowski; Maciej Polewczyk; Anna Polewczyk Journal: Postepy Kardiol Interwencyjnej Date: 2019-09-18 Impact factor: 1.426
Authors: Simon Pecha; Charles Kennergren; Yalin Yildirim; Nils Gosau; Ali Aydin; Stephan Willems; Hendrik Treede; Hermann Reichenspurner; Samer Hakmi Journal: PLoS One Date: 2016-04-27 Impact factor: 3.240